The international law firm Milbank LLP advised the global medical technology company Smith & Nephew plc on the acquisition of Atracsys Sàrl, a Switzerland-based provider of optical tracking technology used in computer-assisted surgery.
Atracsys’ fusionTrack 500 optical tracking camera will be a core enabling technology for Smith & Nephew’s multi-asset digital surgery and robotic ecosystem, including, initially, in its next-generation robotics platform due for commercial release in 2020. The fusionTrack 500 offers superior measurement speed and latency performance, supporting reduced procedure times, as well as increased accuracy resulting in finer precision surgical tasks, such as bone cuts, compared to existing tracking technology.
Smith & Nephew is a portfolio medical technology business with leadership positions in Orthopaedics, Advanced Wound Management and Sports Medicine, more than 16,000 employees and a presence in more than 100 countries. Annual sales in 2018 were $4.9 billion. Smith & Nephew is a member of the FTSE100.
The acquisition is expected to be completed during the third quarter of 2019. The commercial terms have not been disclosed.
A Milbank team led by Martin Erhardt advised Smith & Nephew plc in relation to the acquisition.
Advisor to Smith & Nephew: Milbank LLP
Martin Erhardt (lead, Corporate/M&A), Alexander Rinne (Antitrust), Dominik Waldvogel, Lucas Kleinschmitt (both Corporate/M&A), Alexander Zyrewitz (Antitrust, all Munich).
